Abstract
Disease: Herpes simplex virus infections. Etiologic Agents: Herpes simplex virus types 1 and 2. Source: Human to human spread of infection.
Clinical Manifestations: Oropharyngeal infections, eczema herpeticum, keratoconjunctivitis, genital infections, neonatal infections, encephalitis, meningoencephalitis, nosocomial infections, and infections in the immunocompromised patient.
Pathology: Primary and recurrent infections, the latter originating from activation of infection in latently infected sensory neurons. Commonly, a restricted mucocutaneous vesiculation and ulceration; occasionally, a necrotizing systemic disease. Type 1 virus is commonly associated with oropharyngeal infections, type 2 is commonly associated with genital infections.
Laboratory Diagnosis: Virus isolation or demonstration of viral antigens in secretions or infected tissue specimens. Serology by observations of specific IgG, IgM, and/or IgA antibody response. Typing of virus by type-specific, usually monoclonal antibodies; demonstration of virus-type-related antibodies by means of type-specific viral antigen preparations.
Epidemiology: Worldwide, most commonly subclinical infection, transmission essentially by virus-containing secretions from oropharyngeal or genitourinary tracts. Circulation of virus is maintained by spread of virus from activated latent infections.
Treatment: Antiviral drugs such as acyclovir (Zovirax).
Prevention and Control: Active immunization with experimental vaccines and passive immunization with hyperimmune immunoglobulin preparations are under evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature Cited
Alestig, K., L. Burman, A. Forkman, K. Lovgren, M. Forsgren, T. Bergstrom, E. Dahlqvist, and A. Fryden. 1984. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomized multicentre study in consecutive Swedish patients. Lancet 2: 707 – 711.
Alexander, I., C. R. Ashley, K. J. Smith, J. Harbour, A. P. Roome, and J. M. Darville. 1985. Comparison of ELISA with virus isolation for the diagnosis of genital herpes. J. Clin. Pathol. 38: 554 – 557.
Almeida, J. D. 1983. Uses and abuses of diagnostic electron microscopy, p. 147–158. InP. Bachman (ed.), Current topics in microbiology and immunology. New developments in diagnostic virology, vol. 104. Springer-Verlag KG, Berlin.
Andrewes, C. H, and E. A. Carmichael. 1930. A note on the presence of antibodies to herpes virus in post-encephalitis and other human sera. Lancet 1: 857 – 858.
Ashley, R., J. Benedetti, and L. Corey. 1985. Humoral immune response to HSV-1 and HSV-2 proteins in patients with primary genital herpes. J. Med. Virol. 17: 153 – 166.
Baucke, R. B., and P. G. Spear. 1979. Membrane proteins specified by herpes simplex viruses V. Identification of an Fc-binding glycoprotein. J. Virol. 32: 779 – 789.
Baumann, R. J., J. W. Walsh, R. L. Gilmore, C. Lee, P. Wong, H. D. Wilson, and W. R. Markesbery. 1985. Brain biopsy in cases of neonatal herpes simplex encephalitis. Neurosurgery 16: 619 – 624.
Berman, P. W., T. Gregory, D. Crase, and L. A. Lasky. 1985. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227: 1490 – 1492.
Bishal, F. R., and N. A. Labzoffsky. 1974. Stability of different viruses in a newly developed transport medium. Can. J. Microbiol. 20: 75 – 80.
Brock, D. J., and S. van Heyningen. 1983. A simple method for ranking the affinities of monoclonal antibodies. J. Immunol. Methods 62: 147 – 153.
Brown, Z. A., L. A. Vontver, J. Benedetti, C. W. Critchlow, D. E. Hackok, C. J. Sells, S. Berry, and L. Corey. 1985. Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding. Am. J. Obstet. Gynecol. 153: 24 – 30.
Bryson, Y., M. Dillon, M. Lovett, D. Bernstein, E. Garratty, and J. Sayre. 1985. Treatment of first episode genital HSV with oral acyclovir: long term follow-up of recurrences. Scand. J. Infect. Dis. Suppl. 47: 70 – 79.
Buchman, T. G., B. Roizman, G. Adams, and B. HewittStover. 1978. Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J. Infect. Dis. 138: 488 – 498.
Burns, W. H., R. Saral, G. W. Santos, O. L. Laskin, P. S. Lietman, C. McLaren, and D. W. Barry. 1982. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1: 421 – 423.
Bzik, D. J., B. A. Fox, N. A. DeLuka, and S. Person. 1984. Nucleotide sequence specifying the glycoprotein gene, gB of herpes simplex virus type 1. Virology 133: 301 – 314.
Camacho, A., and P. G. Spear. 1978. Transformation of hamster embryofibroblasts by a specific fragment of the herpes simplex virus genome. Cell 15: 993 – 1002.
Campbell, A. M. 1984. The production and characterization of human and rodent hybridomas, p. 99-101. InR. H. Burdon and P. H. van Knippenberg (ed). Monoclonal antibody technology. Elsevier Science Publishing Co., New York.
Centifanto, Y. M., D. M. Drylic, S. L. Deardourff, and H. E. Kaufman. 1972. Herpesvirus type 2 in male genito-urinary tract. Science 178: 318 – 319.
Chuang, T. Y., W. P. D. Su, H. O. Perry, D. M. Ilstrup, and L. T. Kurland. 1983. Incidence and trend of herpes progenitalis. Clin. Proc. 58: 436 – 441.
Clayton, A.-L., U. Beckford, C. Roberts, S. Sutherland, A. Druse, J. Best, and S. Chantler. 1985. Factors influencing the sensitivity of herpes simplex virus detection in a simultaneous enzyme-linked immunosorbent assay using monoclonal antibodies. J. Med. Virol. 17: 275 – 282.
Coleman, R. M., A. J. Nahmias, S. C. William, D. J. Phillips, C. M. Black, and C. B. Reimer. 1985. IgG subclass antibodies to herpes simplex virus. J. Infect. Dis. 151: 929 – 936.
Coleman, R. M., L. Pereira, P. D. Bailey, D. Dondero, C. Wickliffe, and A. J. Nahmias. 1983. Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18: 287 – 291.
Corey, L. 1986. Laboratory diagnosis of herpes simplex virus infections. Principles guiding the development of rapid diagnostic tests. Diagn. Microbiol. Infect. Dis. 4(Suppl. 3): 1118 – 1198.
Cremer, N. E., C. K. Cossen, C. V. Hansen, and G. R. Shell. 1982. Evaluation and reporting of enzyme immunoassay determinations of antibody to herpes simplex virus in sera and cerebrospinal fluid. J. Clin. Microbiol. 15: 815 – 823.
Davis, W. B., J. A. Taylor, and J. E. Oakes. 1979. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J. Infect. Dis. 140: 534 – 539.
Duermeyer, W. Z., and J. van der Veen. 1978. Specific detection of IgM antibodies by ELISA, applied in hepatitis A. Lancet 2: 684 – 685.
Fayram, S. L., S. Aarnaes, and L. M. de la Maza. 1983. Comparison of Culturset to a conventional tissue cul- ture-fluorescent-antibody technique for isolation and identification of herpes simplex virus. J. Clin. Microbiol. 18: 215 – 216.
Feorino, P. M., S. L. Shore, and C. B. Reimer. 1977. Detection by indirect immunofluorescence of Fc receptors in cells acutely infected with herpes simplex virus. Int. Arch. Allergy Appl. Immunol. 53: 222 – 233.
Field, H. J., and G. Darby. 1980. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob. Agents Chemother. 17: 209 – 216.
Finter, N. B. 1969. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. Gen. Virol. 5: 419 – 427.
Frame, B., J. B. Mahony, N. Balachandran, W. E. Rawls, and M. A. Chernensky. 1984. Identification and typing of herpes simplex virus by enzyme immunoassay with monoclonal antibodies. J. Clin. Microbiol. 20: 162 – 166.
Friedman, M. G., and N. Kimmel. 1982. Herpes simplex virus specific serum immunoglobulin A: detection in patients with primary or recurrent herpes infections and in healthy adults. Infect. Immun. 37: 374 – 377.
Frietz, M. E., and A. J. Nahmias. 1972. Reversal polarity in transmembrane potentials of cells infected with herpesviruses. Proc. Soc. Exp. Biol. Med. 139: 1159 – 1161.
Fung, J. C., J. Shanley, and R. C. Tilton. 1985. Comparison of the detection of herpes simplex virus in direct clinical specimens with herpes simplex virus-specific DNA probes and monoclonal antibodies. J. Clin. Microbiol. 22: 748 – 753.
Furman, P. A., M. H. St. Clair, and T. Spector. 1984. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase. J. Biol. Chem. 259: 9575 – 9579.
Fyfe, J. A., P. M. Keller, P. A. Furman, R. L. Miller, and G. B. Elion. 1978. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound 9-(2-hydroethoxymethyl) guanine. J. Biol. Chem. 253: 8721 – 8727.
Georgiades, J. A., J. Montgomery, T. K. Hughes, D. Jensen, and S. Baron. 1982. Determinants of protection by human immune globulin against herpes neonatorum. Proc. Soc. Exp. Biol. 170: 291 – 297.
Gilljam, G., V. A. Sundqvist, A. Linde, P. Pihlstedt, A. E. Eklund, and B. Wahren. 1985. Sensitive analytic ELISAs for subclass herpes virus IgG. J. Virol. Methods 10: 203 – 214.
Gleaves, C. A., D. J. Wilson, A. D. Wold, and T. F. Smith. 1985. Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation. J. Clin. Microbiol. 21: 29 – 32.
Grillner, L., and M. Landquist. 1983. Enzyme-linked immunosorbent assay for detection and typing of herpes simplex virus. Eur. J. Clin. Microbiol. 2: 39 – 42.
Gruter, W. 1920. Experimentelle und Klinische Unter- suchungen uber den sogenannten Herpes corneae. Ber. Versam. Deutsch. Ophtalm. Ges. 42: 162 – 166.
Hampar, B., M. Zweig, D. Showalter, V. Bladen, and C. W. Riggs. 1985. Enzyme-linked immunosorbent assay for determination of antibodies against herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 21: 496 – 500.
Harger, J. H., G. J. Pazin, J. A. Armstrong, M. C. Breinig, and M. Ho. 1983. Characteristics and management of pregnancy in woman with genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 145: 784 – 791.
Hayden, F. G., A. S. Sorensen, and J. A. Bateman. 1983. Comparison of the lmmulok Culturset kit and virus isolation for detection of herpes simplex virus in clinical specimens. J. Clin. Microbiol. 28: 222 – 224.
Hayward, G. S., R. J. Jacob, S. C. Wadsworth, and B. Roizman. 1975. Anatomy of herpes simplex virus DNA; evidence for four populations of molecules that differ in the relative orientations of their long and short segments. Proc. Natl. Acad. Sci. USA 72: 4243 – 4247.
Jarrat, M. 1983. Herpes simplex infection. Arch. Dermatol. 119: 99 – 103.
Jeansson, S., M. Forsgren, and B. Svennerholm. 1983. Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18: 1160 – 1166.
Johansson, P. J. H., T. Hallberg, V.-A. Oxelius, A. Grubb, and J. Blomberg. 1984. Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes’ simplex virus type 1. J. Virol. 50: 796 – 804.
Johansson, P. J. H., E. B. Myhre, and J. Blomberg. 1985. Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species. J. Virol. 56: 489 – 494.
Johnson, I. B., R. W. Leavitt, and D. F. Richards. 1984. Evaluation of the Virocult transport tube for isolation of herpes simplex virus from clinical specimens. J. Clin. Microbiol. 20: 120 – 122.
Johnson, R. T. 1982. Viral infections of the nervous system. Raven Press, New York.
Jure tic, M. 1966. Natural history of herpetic infection. Helv. Paediatr. Acta 21: 356 – 368.
Kampe, P., A. Knoblich, M. Dietrich, and D. Falke. 1985. Differences in humoral immunogenicity between herpes simplex virus types 1 and 2. J. Gen. Virol. 66: 2215 – 2223.
Kjeldsberg, E. 1980. Application of electron microscopy in viral diagnosis. Pathol. Res. Pract. 167: 3 – 21.
Klein, R. J., and A. E. Friedmann-Kien. 1977. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate. Antimicrob. Agents Chemother. 12: 577 – 581.
Knoblich, A., P. Kampe, V. Harle-Grupp, and D. Falke. 1983. Kinetics and genetics of herpes simplex virus-induced antibody formation in mice. Infect. Immun. 39: 15 – 23.
Kristensson, K., E. Lycke, and J. Sjostrand. 1972. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. (Berlin) 17: 44 – 53.
Kristensson, K., I. Nennesmo, L. Persson, and E. Lycke. 1982. Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brain stem nuclei. J. Neurol. Sci. 54: 149 – 156.
Kulski, J. K., and M. Norval. 1985. Nucleic acid probes in diagnosis of viral diseases of man. Brief review. Arch. Virol, 83: 3 – 15.
Lakeman, A. D., A. J. Nahmias, and R. J. Whitley. 1986. Analysis of DNA from recurrent genital herpes simplex virus isolates by restrictive endonuclease digestion. Sex. Transm. Dis. 13: 61 – 66.
Langer, P. R., A. A. Waldrop, and D. C. Ward. 1981. Enzymatic synthesis of biotin-labelled polynucleotides: novel nucleic acid affinity probes. Proc. Natl. Acad. Sci. USA 78: 6633 – 6637.
Leary, J. J., D. J. Brigati, and D. C. Ward. 1983. Rapid and sensitive colorimetric method for visualizing biotin-labelled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bioblots. Proc. Natl. Acad. Sci. USA 80: 4045 – 4049.
Lee, F. K., R. M. Coleman, L. Pererira, P. D. Bailey, M. Tatsuno, and A. J. Nahmias. 1985. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol. 22: 641 – 644.
Lehrman, S. N., J. N. Douglas, L. Corey, and D. W. Barry. 1986. Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity. Ann. Intern. Med. 104: 786 – 790.
Lycke, E. 1985. Virus-induced changes in neural cells, p. 509–529. InA. Lajhta (ed.), Handbook of neurochemistry. vol. 10. Plenum Publishing Co., New York.
Lycke, E., K. Kristensson, B. Svennerholm, A. Vahlne, and R. Ziegler. 1984. Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J. Gen. Virol. 65: 55 – 64.
Lowenstein, A. 1919. Aetiologische Untersuchungen uber den fieberhaften Herpes. Munch. Med. Wochenschr. 66: 769 – 770.
McLaren, C., M. N. Ellis, and G. A. Hunter. 1983. A colorimetric assay for the measurement of the sensitivity of herpes simplex virus to antiviral agents. Antiviral Res. 3: 223 – 234.
McLaren, C., C. D. Sibrack, and D. W. Barry. 1982. Spectrum of sensitivity to acyclovir of herpes simplex virus clinical isolates. Am. J. Med. 73: 376 – 379.
Merriman, H., S. Woods, C. Winter, A. Fahnlander, and L. Corey. 1984. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex infection. J. Infect. Dis. 149: 505 – 510.
Mertz, G. J., O. Schmidt, J. L. Jourden, M. E. Guinan, M. L. Remington, A. Fahnlander, and L. Corey. 1985. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex. Transm. Dis. 12: 33 – 39.
Mindel, A. 1984. Long term oral acyclovir in disseminated mucocutaneous herpes simplex: a case report. Br. J. Vener. Dis. 60: 125 – 126.
Mindel, A., and S. Sutherland. 1983. Genital herpes—the disease and its treatment including intravenous acyclovir. J. Antimicrob. Chemother. 12(Suppl. B): 51 – 59.
Morris, G. E., R. M. Coleman, B. B. Benetato, and A. J. Nahmias. 1985. Persistence of serum IgA antibodies to herpes simplex, varicella-zoster, cytomegalovirus, and rubella virus detected by enzyme-linked immunosorbent assays. J. Med. Virol. 6: 343 – 349.
Nahmias, A. J., and W. R. Dowdle. 1968. Antigenic and biologic differences in herpesvirus hominis. Prog. Med. Virol. 10: 110 – 159.
Nahmias, A. J., and B. Roizman. 1973a. Infection with herpes simplex viruses 1 and 2. N. Engl. J. Med. 289:667– 674.
Nahmias, A. J., and B. Roizman. 1973b. Infection with herpes simplex viruses 1 and 2. N. Engl. J. Med. 289: 719 – 725.
Nahmias, A. J., and B. Roizman. 1973c. Infection with herpes simplex viruses 1 and 2. N. Engl. J. Med. 289: 781 – 789.
Nahmias, A. J., and A. M. Visintine. 1976. Herpes simplex, p. 156–190. InJ. Remington and J. Klein (ed.), Infectious diseases of the fetus and newborn. The W. B. Saunders Co., Philadelphia.
Nahmias, A. J., A. M. Visintine, C. B. Reimer, I. Del Buano, S. L. Shore, and S. E. Starr. 1977. Herpes simplex virus infection of the fetus and newborn, p. 63–77. InS. Krugman and A. Gershon (ed.), Symposium on infection of the fetus and newborn infant. Progress in clinical and biological research. Alan R. Liss, New York.
Nahmias, A., C. Wickliffe, J. Pipkin, A. Leibowitz, and R. Hutten. 1971. Transport media for herpes simplex viruses types 1 and 2. Appl. Microbiol. 22: 451 – 454.
Nahmias, A. J., R. J. Whitley, A. N. Visintine, Y. Takei, C. A. Alford, Jr., and the Collaborative Antiviral Study Group. 1982. Herpes simplex encephalitis. Laboratory evaluations and their diagnostic significance. J. Infect. Dis. 145: 829 – 836.
Nash, A. A., J. Phelan, and P. Wildy. 1981. Cell mediated immunity in herpes simplex infected mice: H2 mapping of the delayed type hypersensitivity response and the antiviral T cell response. J. Immunol. 126: 1260 – 1268.
Nerurkar, L. S., M. Namba, G. Brashears, A. J. Jacob, Y. J. Lee, and J. L. Sever. 1984a. Rapid detection of herpes simplex virus in clinical specimens by use of a capture biotin-streptavidin enzyme-linked immunosorbent assay. J. Clin. Microbiol. 20: 109 – 114.
Nerurkar, L. S., M. Namba, and J. L. Sever. 1984b. Comparison of standard tissue culture, tissue culture plus staining, and direct staining for detection of genital herpes simplex virus infection. J. Clin. Microbiol. 19: 631 – 633.
Nick, S., P. Kampe, A. Knoblick, B. Metzger, and D. Falke. 1986. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2. J. Gen. Virol. 67: 1015 – 1024.
Nilheden, E., S. Jeansson, and A. Vahlne. 1983. Typing of herpes simplex virus by an enzyme-linked immunosorbent assay with monoclonal antibodies. J. Clin. Microbiol. 17: 677 – 680.
Nilsen, A. 1985. Genital herpes. Scand. J. Infect. Dis. Suppl. 47: 51 – 57.
Para, M. F., L. Goldstein, and P. G. Spear. 1982. Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex viruses types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J. Virol. 41: 137 – 144.
Parris, D. H., and J. E. Harrington. 1982. Herpes simplex virus variants resistant to high concentrations of acyclovir exists in clinical isolates. Antimicrob. Agents Chemother. 22: 71 – 77.
Pedersen, B., S. Moller-Andersen, A. Klauber, E. Ottoway, J. U. Pranse, C. Zhong, and B. Norrild. 1982. Secretory IgA specific herpes simplex virus in lacrimal fluid from patients with herpes keratitis—a possible diagnostic parameter. Br. J. Ophthalmol. 66: 648 – 653.
Pereira, L. 1982. Monoclonal antibodies to herpes simplex viruses 1 and 2, p. 119–138. InJ. G. R. Hurrell (ed.), Monoclonal hybridoma antibodies: techniques and applications. CRC Press, Boca Raton, Fla.
Pereira, L., D. V. Dondero, D. Gallo, V. Devlin, and J. D. Woodie. 1982. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect. Immun. 35: 363 – 367.
Prentice, H. G. 1983. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients. J. Antimicrob. Chemother. 12(Suppl. B): 153 – 159.
Puga, A., E. M. Cantin, and A. L. Notkins. 1982. Homology between murine and human cellular DNA sequences and the terminal repetition of S component of herpes simplex virus type 1 in DNA. Cell 31: 81 – 89.
Rawls, W. E. 1979. Herpes simplex virus types 1 and 2 and herpesvirus simiae, p. 336–346. InE. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections. American Public Health Association, Washington, D.C.
Rawls, W. E. 1985. Herpes simplex virus, p. 537–540. InB. N. Fields, D. M. Knipe, J. L. Melnick, R. M. Chanock, B. Roizman, and R. E. Shope (ed.), Virology. Raven Press, New York.
Read, G. S., and N. Frenkel. 1983. Herpes simplex virus mutants defective in the virion associated shut-off of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 46: 498 – 512.
Redfield, D. C., D. D. Richman, S. Albanil, M. N. Oxmanil, and G. M. Wahl. 1983. Detection of herpes simplex virus in clinical specimens by DNA hybridization. Diagn. Microbiol. Infect. Dis. 1: 117 – 128.
Reeves, W. C., L. Corey, H. G. Adams, L. A. Vontver, and K. K. Holmes. 1981. Risk of recurrence after first episode of genital herpes. N. Engl. J. Med. 305: 315 – 319.
Reyes, G. R., R. La Femina, S. D. Hayward, and G. S. Hayward. 1979. Morphological transformation by DNA fragments of human herpesviruses: evidence for two distinct transforming regions in herpes simplex virus types 1 and 2 and lack of correlation with biochemical transfer of thymidine kinase gene. Cold Spring Harbor Symp. Quant. Biol. 44: 629 – 641.
Ribaric, V. 1976. The incidence of herpetic keratitis among population. Ophthalmologica 173: 19 – 22.
Richman, D., N. Schmidt, S. Plotkin, R. Yolken, M. Cherensky, K. Mcintosh, and M. Mattheis. 1984. Summary of a workshop on new and useful methods in rapid viral diagnosis. J. Infect. Dis. 150: 941 – 951.
Rock, D. L., and N. W. Frazero. 1983. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature (London) 302: 523 – 525.
Roizman, B. 1982. The family Herpesviridae: general de scription, taxonomy and classification, p. 1–23. InB. Roizman (ed.), The herpesviruses, vol. 1. Plenum Publishing Co., New York.
Roizman, B., B. Norrild, C. Chah, and L. Pereira. 1984. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus type 2 glycoprotein lacking a known type 1 counter part. Virology 133: 242 – 247.
Rubin, S. J., and S. Rogers. 1984. Comparison of Culturset and primary rabbit kidney cell culture for the detection of herpes simplex virus. J. Clin. Microbiol. 19: 920 – 922.
Saito, Y., R. W. Price, D. A. Rottenberg, J. J. Fox, T.-L. Su, and K. A. Watanabe. 1982. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 217: 1151 – 1153.
Saral, R., R. F. Ambinder, W. H. Burns, C. A. Angelopulos, D. E. Griffin, P. J. Burke, and P. S. Lietman. 1983. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. Ann. Intern. Med. 99: 773 – 779.
Schmidt, N. J. 1982. Further evidence for common antigens in herpes simplex and varicella-zoster viruses. J. Med. Virol. 9: 27 – 36.
Schmidt, N. J., and D. Gallo. 1984. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses. J. Med. Virol. 13: 1 – 12.
Schmidt, O. W., K. H. Fife, and L. Corey. 1984. Reinfection is an uncommon occurrence in patients with symptomatic recurrent genital herpes. J. Infect. Dis. 149: 645 – 646.
Schmitz, H., U. von Deimling, and B. Flehmig. 1980. Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J. Gen. Virol. 50: 59 – 68.
Schnipper, L. E., and C. S. Crumpacker. 1980. Resistance of herpes simplex virus to acycloguanosine: role of virus thymidine kinase and DNA polymerase loci. Proc. Natl. Acad. Sci. USA 77: 2270 – 2273.
Shani, L., R. Szanton, R. David, Y. Yassur, and I. Sarov. 1985. Studies on HSV specific IgA antibodies in lacrimal fluid from patients with herpes keratitis by solid phase radioimmunoassay. Exp. Res. 4: 103 – 111.
Sjogren-Jans son, E. and S. Jeansson. 1985. Large-scale production of monoclonal antibodies in dialysis tubing. J. Immunol. Methods 84: 359 – 364.
Skoldenberg, B., K. Alestig, L. Burman, A. Forkman, K. Lovgren, R. Norrby, G. Stjernstedt, M. Forsgren, T. Bergstrom, E. Dahlqvist, A. Fry den, K. Norlin, E. Olding-Stenkvist, and I. Uhnoo. 1984. Acyclovir versus vi- darabine in herpes simplex encephalitis. Randomised multicenter study in consecutive Swedish patients. Lancet 2: 707 – 711.
Smith, I. W., B. Barr, K. Slatford, and D. H. H. Robertson. 1985. Restriction enzyme analysis of herpes simplex virus isolates from known contacts of patients with genital herpes. Lancet 1: 979.
Smith, I. W., J. F. Pedutherer, and D. H. H. Robertson. 1973. Characterization of genital strains of herpesvirus hominis. Br. J. Vener. Dis. 49: 385 – 390.
Snowden, B. W., P. R. Kinchington, K. L. Powell, and I. W. Halliburton. 1985. Antigen and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammilitis virus and equine herpesvirus type 1. J. Gen. Virol. 66: 231 – 247.
Spear, P. G. 1985. Glycoproteins specified by herpes simplex viruses, p. 315–356. InB. Roizman (ed.), The herpesviruses, vol. 3. Plenum Press, New York.
Spruance, S. L., J. C. Overall, E. R. Kern, G. G. Kreuger, V. Pliam, and W. Miller. 1977. The natural history of recurrent herpes labialis. Implications of antiviral therapy. N. Engl. J. Med. 297: 69 – 75.
Strand, A., A. Vahlne, B. Svennerholm, J. Wallin, and E. Lycke. 1986. Asymptomatic viruses shedding in men with genital herpes infection. Scand. J. Infect. Dis. 18: 195 – 197.
Strand, S. E., H. E. Takiff, M. Seidlin, S. Bachrach, L. Lininger, J. J. DiGiovanni, K. A. Westerha, H. A. Smith, S. N. Lehrman, T. Creagh-Kirk, and D. W. Ailing. 1984. Suppressing of frequently recurring genital herpes. A placebo controlled double-blind trial of oral acyclovir. N. Engl. J. Med. 310: 1545 – 1550.
Sullivan-Boyai, J., H. Hull, C. Wilson, and L. Corey. 1983. Neonatal herpes simplex virus infection in King County, Washington. J.A.M.A. 250: 3059 – 3062.
Sutherland, S., B. Morgan, A. Mindel, and W. L. Chan. 1986. Typing and subtyping of herpes simplex virus isolates by monoclonal fluorescence. J. Med. Virol. 18: 235 – 245.
Svennerholm, B., S. Olofsson, S. Jeansson, A. Vahlne, and E. Lycke. 1984. Herpes simplex virus type-selective en- zyme-linked immunosorbent assay with Helix pomatialectin purified antigens. J. Clin. Microbiol. 19: 235 – 239.
Svennerholm, B., A. Vahlne, G. B. Lowhagen, A. Widell, and E. Lycke. 1985. Sensitivity of HSV strains isolated before and after treatment with acyclovir. Scand. J. Infect. Dis. Suppl. 47: 149 – 154.
Svennerholm, B., A. Vahlne, and E. Lycke. 1979. Inhibition of herpes simplex virus infection in tissue culture by trisodium phosphonoformate. Proc. Soc. Exp. Med. Biol. 161: 115 – 118.
Svennerholm, B., A. Vahlne, and E. Lycke. 1981. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs. Arch. Virol. 69: 43 – 48.
Swierkosz, E. M., M. Q. Arens, R. R. Schmidt, and T. Armstrong. 1985. Evaluation of two immunofluorescence assays with monoclonal antibodies for typing of herpes simplex virus. J. Clin. Microbiol. 21: 643 – 644.
Thin, R. N., W. Aha, J. D. Parker, C. S. Nicol, and G. Canti. 1975. Value of Papanicolaou-stained smears in the diagnosis of trichomoniasis, candidiasis and cervical herpes simplex virus infection in women. Br. J. Vener. Dis. 51: 116 – 118.
Thompson, R. J. 1984. Are monoclonal antibodies the end of radioimmunoassay? Trends Biochem. Sci. 7: 419 – 420.
Vahlne, A., B. Svennerholm, and E. Lycke. 1979. Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. J. Gen. Virol. 44: 217 – 225.
Vandvik, B., F. Vartdal, and E. Norrby. 1982. Herpes simplex encephalitis: intrathecal synthesis of oligoclonal virus-specified IgG, IgA and IgM antibodies. J. Neurol. 228: 25 – 38.
van Dyke, R. B., and J. D. Connor. 1985. Uptake of 1–125- iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir. J. Infect. Dis. 152: 1206 – 1211.
van Loon, A. M., F. M. V. Heessen, M. van der Logt, and J. van der Veen. 1981. Direct enzyme-linked immunosorbent assay that uses peroxidase labelled antigen for determination of immunoglobulin M antibody to cytomegalovirus. J. Clin. Microbiol. 13: 416 – 422.
van Loon, A. M., M. van der Logt, F. M. V. Heessen, and J. van der Veen. 1985. Use of labelled antigen for the detection of immunoglobulin M and A antibody to herpes simplex virus in serum and cerebrospinal fluid. J. Med. Virol. 15:183–195.
Vestergaard, B. F. 1980. Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis. Rev. Infect. Dis. 2: 899 – 913.
Wahren, B., J. Harmenberg, V.-A. Sundqvist, B. Leven, and B. Skoldenberg. 1983. A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J. Virol. Methods. 6: 141 – 149.
Warford, A. L., W. G. Eveland, C. A. Strong, R. A. Levy, and K. A. Rekrut. 1984. Enhanced virus isolation rate by use of the transporter for a regional laboratory. J. Clin. Microbiol. 19: 561 – 562.
Watkins, J. F. 1965. Adsorption of sensitized sheep erythrocytes to HeLa cells infected with herpes simplex virus. Nature 202: 1364 – 1365.
Westmoreland, D., and J. F. Watkins. 1974. The IgG receptor induced by herpes simplex virus: studies using radio- iodinated IgG. J. Gen. Virol. 24: 167 – 178.
Whitley, R. J. 1985. Epidemiology of herpes simplex viruses, p. 1–44. InB. Roizman (ed.), The herpesviruses, vol. 3. Plenum Press, New York.
Whitley, R. J., C. A. Alford, M. S. Hirsch, R. T. Schooley, J. P. Luby, F. Y. Aok, D. Hanley, A. J. Nahmias, and S. J. Soong. 1986. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 314: 144 – 149.
Whitley, R. J., S. J. Soong, M. S. Hirsch, A. W. Karchmer, R. Dolin, G. Galasso, J. K. Dunnick, C. A. Alford, and the NIAD Colloborative Antiviral Study Group. 1981. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N. Engl. J. Med. 304: 313 – 318.
Wildy, P. 1973. Herpes history and classification, p. 1–25. InA. S. Kaplan (ed.), The herpesvirus. Academic Press, New York.
Yeager, A. S. 1984. Genital herpes simplex infections: effect of asymptomatic shedding and latency on management of infections in pregnant women and neonates. J. Invest. Dermatol. 83: 53 – 56.
Yolken, R. H. 1982. Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects. Rev. Infect. Dis. 4: 35 – 68.
Zheng, Z. M., D. R. Mayo, and G. D. Hsuing. 1983. Comparison of biological, biochemical, immunological and immunochemical techniques for typing of herpes simplex virus isolates. J. Clin. Microbiol. 17: 396 – 399.
Ziegler, T., O. H. Meurman, P. P. Arstila, and P. E. Halonen. 1983. Solid-phase enzyme-immunoassay for the detection of herpes simplex virus antigens in clinical specimens. J. Virol. Methods 7: 1 – 9.
Zinsser, H., and F. F. Tang. 1929. Further experiments on agent of herpes. J. Immunol. 17: 343 – 355.
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Lycke, E., Jeansson, S. (1988). Herpesviridae: Herpes Simplex Virus. In: Laboratory Diagnosis of Infectious Diseases Principles and Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3900-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3900-0_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8394-2
Online ISBN: 978-1-4612-3900-0
eBook Packages: Springer Book Archive